Susan G. Komen® San Diego announces executive leadership change

Meredith Hall-Chand to succeed Shaina Gross, outgoing President & CEO

SAN DIEGO (February 25, 2020)—Susan G. Komen San Diego has appointed Meredith Hall-Chand, Director of Development, as its interim president and CEO. Hall-Chand will succeed Shaina Gross, Komen San Diego’s president and CEO, who is leaving the organization after two and a half years, for a program development position at a San Diego nonprofit.

Komen San Diego’s Board of Directors has formed a search committee for a permanent president and CEO, chaired by Merrilee Neal, chair of the Komen San Diego Board of Directors. A national search will begin in March 2020 and updates will be made available on Komen San Diego’s website.

During Gross’ tenure, she led Komen San Diego to be one of the first affiliates in the nation to provide direct patient services, increased the financial stability of the organization, and reimagined Komen’s work in health equity and

Meredith Hall-Chand
Interim President and CEO

disparities. She created a prestigious Advisory Council and led the organization as they successfully changed multiple state laws to increase coverage for breast cancer patients.

“The board of Susan G. Komen San Diego thanks Shaina for steering the organization forward over the last few years,” said Neal. “We appreciate the leadership she provided during her tenure and are grateful to her for leaving Komen on solid ground for the next CEO. We wish her well and thank her for her service to Komen and the thousands of San Diego women fighting breast cancer.”

Hall-Chand, who has been with Komen for two years, has a decade of non-profit leadership experience. She will lead San Diego County’s prominent breast cancer organization beginning March 2 as a national search for a permanent CEO commences.

“Our board is confident in the appointment of Meredith as Interim CEO,” said Neal. “With the support of an experienced and steadfast board and management team, we know Meredith will exemplify visionary leadership and be successful in major fundraising objectives.”

During Hall-Chand’s two years with Komen San Diego, the organization’s grant funding and major donors have grown by 150 percent, its signature fundraising events have been transformed leading to a 25 percent growth in attendees and revenue, and a robust fundraising strategy has led to an increase in donor retention. In previous roles, she has led to the development and expansion of new business practices and programs, managed large numbers of staff and volunteers, and secured more than $5 million in gifts for various causes. She has served on three nonprofit boards, volunteered for several community organizations, and successfully passed a bill through the state legislature as co-founder of CA K.I.D.S., which updated California’s mandated reporter law for child abuse and neglect.

Hall-Chand’s grandmother battled breast cancer and passed away from lymphoma when she was a child, which led to her desire during college to join a team of young women who raised funds for Susan G. Komen.

“I am eager to take on this transition and grateful to Shaina for her tremendous leadership over the past two and a half years,” said Hall-Chand. “She will be missed, but we know she will always be part of the Komen family.”

Since its inception in 1995, Susan G. Komen San Diego has invested nearly $20 million to local breast health services and global breast cancer research. Komen San Diego provides free mammograms, biopsies, ultrasounds, MRIs, care coordination, education and financial assistance for breast cancer patients’ most critical needs during treatment. The organization also has a robust public policy and advocacy arm to ensure healthcare access and scientific progress. Susan G. Komen is the largest nonprofit funder of breast cancer research outside of the U.S. government and much of that investment has been awarded to scientists in San Diego. Nearly 70 percent of our research investment is focused on metastatic disease. For more information, please visit Connect with us on Facebook, Twitter, and Instagram.